ObjectiveSerous tubal intra-epithelial carcinoma (STIC) lesions are thought to be precursors to high-grade serous ovarian cancer (HGSOC), but HGSOC is not always accompanied by STIC. Our study was designed to determine if there are global visual and subvisual microenvironmental differences between fallopian tubes with and without STIC lesions.MethodsComputational image analyses were used to identify potential morphometric and topologic differences in stromal and epithelial cells in samples from three age-matched groups of fallopian tubes. The Benign group comprised normal fallopian tubes from women with benign conditions while the STIC and NoSTIC groups consisted of fallopian tubes from women with HGSOC, with and without STIC lesions, respe...
Tubal ligation keeps the fimbriated end of the fallopian tube intact while interrupting the conduit ...
High-grade serous ovarian carcinoma (HGSOC) is the most frequent type of ovarian cancer and has a po...
SummaryHigh-grade serous ovarian carcinoma presents significant clinical and therapeutic challenges....
Aim and objectives. Identify and evaluate lesions developed in fallopian tubes in breast, ovarian an...
Uterine serous papillary carcinoma (UPSC) is an aggressive tumor, often diagnosed as a metastatic di...
High-grade serous cancer (HGSC) progresses to advanced stages without symptoms and the 5-year surviv...
Background: Mounting evidence suggests the fallopian tube as the origin for ovarian high grade serou...
In recent years it has become clear that many extra-uterine (pelvic) high-grade serous carcinomas (s...
INTRODUCTION: Serous carcinomas are the most frequent histologic type of ovarian and peritoneal canc...
In recent years it has become clear that many extra-uterine (pelvic) high-grade serous carcinomas (s...
OBJECTIVE: A precursor lesion for ovarian carcinoma, tubal intraepithelial carcinoma (TIC), has been...
Epithelial ovarian cancer is the second most common gynaecological cancer, but has the highest fatal...
High grade serous ovarian cancer (HGSC), the most lethal and frequent type of epithelial ovarian can...
Aims: To investigate whether the presence of serous tubal intraepithelial carcinoma (STIC) is associ...
High-grade serous ovarian cancer, also known as high-grade serous carcinoma (HGSC), is the most comm...
Tubal ligation keeps the fimbriated end of the fallopian tube intact while interrupting the conduit ...
High-grade serous ovarian carcinoma (HGSOC) is the most frequent type of ovarian cancer and has a po...
SummaryHigh-grade serous ovarian carcinoma presents significant clinical and therapeutic challenges....
Aim and objectives. Identify and evaluate lesions developed in fallopian tubes in breast, ovarian an...
Uterine serous papillary carcinoma (UPSC) is an aggressive tumor, often diagnosed as a metastatic di...
High-grade serous cancer (HGSC) progresses to advanced stages without symptoms and the 5-year surviv...
Background: Mounting evidence suggests the fallopian tube as the origin for ovarian high grade serou...
In recent years it has become clear that many extra-uterine (pelvic) high-grade serous carcinomas (s...
INTRODUCTION: Serous carcinomas are the most frequent histologic type of ovarian and peritoneal canc...
In recent years it has become clear that many extra-uterine (pelvic) high-grade serous carcinomas (s...
OBJECTIVE: A precursor lesion for ovarian carcinoma, tubal intraepithelial carcinoma (TIC), has been...
Epithelial ovarian cancer is the second most common gynaecological cancer, but has the highest fatal...
High grade serous ovarian cancer (HGSC), the most lethal and frequent type of epithelial ovarian can...
Aims: To investigate whether the presence of serous tubal intraepithelial carcinoma (STIC) is associ...
High-grade serous ovarian cancer, also known as high-grade serous carcinoma (HGSC), is the most comm...
Tubal ligation keeps the fimbriated end of the fallopian tube intact while interrupting the conduit ...
High-grade serous ovarian carcinoma (HGSOC) is the most frequent type of ovarian cancer and has a po...
SummaryHigh-grade serous ovarian carcinoma presents significant clinical and therapeutic challenges....